by European Public Health Alliance | May 31, 2019 | Opinion
George Thurley, Alternate Public Health Member of the European Commission Expert Group on EU Trade Agreements; May van Schalkwyk, Policy Assistant, EPHA As tobacco control measures continue to be strengthened, both within EU national governments as well as across the...
by European Public Health Alliance | May 31, 2019 | Opinion
Gabriel Siles-Brügge, Associate Professor in Public Policy at the University of Warwick & EPHA Scientific Advisor on Trade Policy Significant concerns have been raised regarding the risks posed by investor-to-state dispute settlement (ISDS) for tobacco regulation....
by European Public Health Alliance | May 7, 2019 | Opinion
Asthma is a public health challenge which requires action now. Air pollution is one of the key risk factors requiring urgent action across Europe. Asthma is a chronic disease affecting the airways that affects between 100 and 150 million people globally, with allergy...
by European Public Health Alliance | May 3, 2019 | Opinion
On 3 April, EPHA members VAS-European Independent Foundation in Angiology/Vascular Medicine organised an event in the European Parliament to raise awareness of vascular diseases, with a focus on PAD (Peripheral Arterial Disease). Hosted by MEP Aldo Patriciello (IT,...
by European Public Health Alliance | May 3, 2019 | Opinion
As part of the European Policy Centre’s current series of events on digitalisation, a recent event organised on 8 April addressed the potential impacts of new technologies on healthcare, with a particular focus on healthcare professionals. To what extent is the...
by European Public Health Alliance | May 3, 2019 | Opinion
As trade and investment agreements increasingly focus on “non-tariff barriers” their potential impacts on public health increase. Trade agreements can affect many issues including their impact on antimicrobial resistance which is often overlooked. Unhealthy Trade?...
